Joshua A. Bornhorst

2 weeks ago | healio.com | Bob Herpen |Joshua A. Bornhorst

Key takeaways: Neurofilament light chain holds potential as an indicator of ALS, as in other neurodegenerative conditions. To utilize NfL effectively, a physician with expertise in neurological biomarkers will likely be required. In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for blood-based biomarkers to assist clinicians in early detection and treatment efforts. Healio spoke with Joshua A.

Nov 10, 2023 | thejns.org | Diane Donegan |Joshua A. Bornhorst |JAmie VAn Gompel |John Atkinson

Share Link Copy this link, or click below to email it to a friend Email this content or copy the link directly: The link was not copied. Your current browser may not support copying via this button.